CRNX · Crinetics Pharmaceuticals, Inc. · Executive Compensation
Market Cap
$9.01B
Shares
106.07M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| R. Scott Struthers | President and Chief Executive Officer | $11,628,959 |
| Tobin Schilke | Chief Financial Officer | $4,357,893 |
| Dana Pizzuti | Chief Medical and Development Officer | $3,910,331 |
| Stephen F. Betz | Chief Scientific Officer | $3,827,148 |
| Jeff Knight | Chief Operating Officer | $3,826,671 |
| Marc J. Wilson | Former Chief Financial Officer | $3,255,392 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| R. Scott Struthers | President and Chief Executive Officer | $10,533,579 |
| Marc J. Wilson | Former Chief Financial Officer | $4,434,895 |
| Dana Pizzuti | Chief Medical and Development Officer | $4,209,728 |
| Stephen F. Betz | Chief Scientific Officer | $4,123,937 |
| Jeff Knight | Chief Operating Officer | $4,122,990 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| R. Scott Struthers | President and Chief Executive Officer | $5,747,994 |
| Marc J. Wilson | Former Chief Financial Officer | $2,513,495 |
| Stephen F. Betz | Chief Scientific Officer | $2,496,868 |
| Jeff Knight | Chief Operating Officer | $2,362,362 |
| Dana Pizzuti | Chief Medical and Development Officer | $1,102,038 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| R. Scott Struthers | President and Chief Executive Officer | $4,144,049 |
| Jeff Knight | Chief Operating Officer | $2,980,038 |
| Ajay Madan | Former Chief Development Officer | $2,057,093 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| R. Scott Struthers | President and Chief Executive Officer | $3,826,332 |
| Ajay Madan | Former Chief Development Officer | $1,619,627 |
| Marc. S. Wilson | Chief Financial Officer | $1,579,820 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| R. Scott Struthers | President and Chief Executive Officer | $3,766,662 |
| Alan Krasner | — | $1,545,781 |
| Marc. S. Wilson | Chief Financial Officer | $1,423,808 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| R. Scott Struthers | — | $3,041,435 |
| Alan Krasner | — | $1,571,960 |
| Marc. S. Wilson | — | $1,030,973 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Prasanna Thombre | Treasurer | Appointed | 2026-09-01 |
| Omar White | Secretary | Appointed | 2026-09-01 |
| Charles Wagner | President | Appointed | 2026-09-01 |
| Charles Wagner | sole director of the Surviving Corporation | Appointed | 2026-09-01 |
| Wendell Wierenga | director | Resigned | 2026-09-01 |
| Rogério Vivaldi Coelho | director | Resigned | 2026-09-01 |
| Weston Nichols | director | Resigned | 2026-09-01 |
| Stephanie S. Okey | director | Resigned | 2026-09-01 |
| Matthew K. Fust | director | Resigned | 2026-09-01 |
| Caren Deardorf | director | Resigned | 2026-09-01 |
| Camille L. Bedrosian | director | Resigned | 2026-09-01 |
| R. Scott Struthers | director | Resigned | 2026-09-01 |
| Jeff Knight | Chief Development and Operating Officer | Resigned | 2026-04-10 |
| Jeff Knight | Chief Development and Operating Officer | Resigned | 2026-03-23 |
| Marc J.S. Wilson | employee, officer, director, and from all other positions Consultant holds with the Company | Resigned | 2025-04-04 |
| Marc J.S. Wilson | Chief Financial Officer | Resigned | 2025-04-04 |
| Marc Wilson | Chief Financial Officer | Resigned | 2025-02-24 |
| Tobin "Toby" Schilke | Chief Financial Officer | Appointed | 2025-02-24 |
Key facts
CIK
1658247
CUSIP
22663K107
13F (30d)
162 filings
162 filers
Visit website
Investor relations